As of January 2025, Bioness Medical launched as a focused organization dedicated to advancing rehabilitation technology. The company distributes award-winning non-invasive devices based on functional electrical stimulation (FES), including its L300 Foot Drop System and H200 Hand Rehabilitation System, along with robotic systems and software therapy programs.
Cyborg Score Rationale
Bioness operates in a specialized but fragmented rehabilitation technology market with established products and clinical validation. The January 2025 rebrand and restructuring as a focused organization indicates strategic repositioning, though limited public data on recent financial performance and market share constrains confidence.
Top Insights
Bioness Medical relaunched in January 2025 as a focused rehabilitation technology company, signaling a strategic pivot or organizational restructuring.
Core product portfolio includes award-winning L300 Foot Drop System (2007 Gold Medical Design Excellence Award winner) and NESS H200 Hand Rehabilitation System for CNS disorder patients.
Bioness was acquired by Bioventus in March 2021 and is currently operating as a Bioventus subsidiary, indicating integration into a larger orthopedic and rehabilitation platform.
Company employs 51–200 people and was founded in 2004, with over 20 years of operating history in neurorehabilitation.
Named Competitors
ReWalk — Robotic exoskeletons for spinal cord injury and stroke mobility.
Ekso Exoskeletons — Powered exoskeletons for rehabilitation and industrial applications.
WalkAide — FES system for gait correction and drop foot in stroke and neurological conditions
Zynex Medical — Electrotherapy and stroke rehabilitation devices for home and clinical use
Recent Developments
(January 2025) Bioness Medical relaunched as a focused independent organization dedicated to rehabilitation technology under new CEO Todd Cushman.
(March 2021) Acquired by Bioventus Inc. (NASDAQ: BVS) for $45 million upfront plus up to $65 million in contingent milestone payments.
Open the full interactive Bioness Medical, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.